Skip to main content
. 2023 Nov 28;11(11):e007667. doi: 10.1136/jitc-2023-007667

Figure 5.

Figure 5

Boxplots showing pretreatment stromal tumor-infiltrating lymphocyte (sTIL) levels in pathological complete response (pCR) versus non-pCR patients. (A), All enrolled patients. (B), By study arm.